HRMY CIK: 1802665

Harmony Biosciences Holdings, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.28
FY22:
0.40
FY23:
0.45
FY24:
0.58
FY25:
0.91
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.15
FY22:
0.27
FY23:
0.36
FY24:
0.42
FY25:
0.36
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.43
FY22:
0.67
FY23:
0.81
FY24:
1.00
FY25:
1.27

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.05
FY22:
0.08
FY23:
0.16
FY24:
0.18
FY25:
0.25
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.19
FY22:
0.19
FY23:
0.18
FY24:
0.16
FY25:
0.15
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.19
FY22:
0.40
FY23:
0.47
FY24:
0.66
FY25:
0.87
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.43
FY22:
0.67
FY23:
0.81
FY24:
1.00
FY25:
1.27

All amounts in billions USD Data source:SEC EDGAR